Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is I  [Clear All Filters]
2020
Kaur A, Cho L, Cereb N, Lin P-Y, Yang K-L. Identification of a novel HLA-A*01 variant, HLA-A*01:211, in a Singaporean Malay bone marrow donor. HLA. 2020.
Wang N, Liu X, Shi L, Liu Y, Guo S, Liu W, Li X, Meng J, Ma X, Guo Z. Identification of a prolonged action molecular GLP-1R agonist for the treatment of femoral defects. Biomater Sci. 2020.
Peng L, Xiong Y, Wang R, Zhou H, Xiang L, Gu H. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer. Biosci Rep. 2020.
Li J, Lin Y, Chen L, Qin L, Tan H, Zou J, Zhang D, Nie Y, Wang G, Zhang H, et al. Identification of acquired PIGA mutations and additional variants by next-generation sequencing in paroxysmal nocturnal hemoglobinuria. Int J Lab Hematol. 2020.
Yan Y, Li X, Gao J. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia. J Clin Lab Anal. 2020:e23055.
Bi Y, Tu Z, Zhang Y, Yang P, Guo M, Zhu X, Zhao C, Zhou J, Wang H, Wang Y, et al. Identification of ALPPL2 as a Naive Pluripotent State-Specific Surface Protein Essential for Human Naive Pluripotency Regulation. Cell Rep. 2020;30(11):3917-3931.e5.
Yang K-L, Li C-C, Lin P-Y. Identification of an HLA-B*35:01:01:01 variant, HLA-B*35:01:23, in a Taiwanese individual. HLA. 2020.
Bai K-H, He S-Y, Shu L-L, DA Wang W-, Lin S-Y, Zhang Q-Y, Li L, Cheng L, Dai Y-J. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index. Cancer Med. 2020.
Zhao M, Chen Z, Zheng Y, Liang J, Hu Z, Bian Y, Jiang T, Li M, Zhan C, Feng M, et al. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis. J Cancer Res Clin Oncol. 2020.
Han Y, Yang L, Duan X, Duan F, Nilsson-Payant BE, Yaron TM, Wang P, Tang X, Zhang T, Zhao Z, et al. Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids. bioRxiv. 2020.
Santoro D, Di Loria A, Mirante T, Oliveira DMendes, Laudanna C, Malanga D, Dattilo V, Iaccino E, Marsella R, Ciaramella P. Identification of differentially expressed microRNAs in the skin of experimentally sensitized naturally affected atopic beagles by next-generation sequencing. Immunogenetics. 2020.
Ali SDanish, Alam W, Tayara H, Chong K. Identification of Functional piRNAs Using a Convolutional Neural Network. IEEE/ACM Trans Comput Biol Bioinform. 2020;PP.
Mason CC, Fiol CR, Baker MJ, Nadal-Melsio E, Yebra-Fernandez E, Bicalho L, Chowdhury A, Albert M, Reid AG, Claudiani S, et al. Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy. Br J Haematol. 2020.
Tavares MR, de Castro RVG, Pieri NCG, Cruz NRN, Martins DS, Ambrósio CE, Garcia JM, Camplesi AC, Bressan FF, Toniollo GH. Identification of hepatic progenitor cells in the canine fetal liver. Res Vet Sci. 2020;133:239-245.
Santos AIsabel, Lourenço ASofia, Simão S, da Silva DMarques, Santos DFilipa, de Carvalho APaula Onof, Pereira ACatarina, Izquierdo-Álvarez A, Ramos E, Morato E, et al. Identification of new targets of S-nitrosylation in neural stem cells by thiol redox proteomics. Redox Biol. 2020;32:101457.
Manning JA, Windley SP, Sandow JJ, Shah SS, Western P, Wilhelm D, Kumar S. Identification of novel interacting partners of the NEDD4 ubiquitin ligase in mouse testis. J Proteomics. 2020;223:103830.
Bai W-Y, Wang L, Ying Z-M, Hu B, Xu L, Zhang G-Q, Cong P-K, Zhu X, Zou W, Zheng H-F. Identification of PIEZO1 polymorphisms for human bone mineral density. Bone. 2020:115247.
Kong F-E, Tang Y-Q, Gong Y-F, Mo J-Q, Zhao Y, Li M-M, Cheng W, Li H-L, Zhu W-J, Liu S-S, et al. Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model. Hepatol Int. 2020.
Burns MA, Place AE, Stevenson KE, Gutierrez A, Forrest S, Pikman Y, Vrooman LM, Harris MH, Hunt SK, O'Brien JE, et al. Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001. Pediatr Blood Cancer. 2020:e28719.
Iwata T, Mizuno N, Nagahara T, Kaneda-Ikeda E, Kajiya M, Kitagawa M, Takeda K, Yoshioka M, Yagi R, Takata T, et al. Identification of regulatory mRNA and microRNA for differentiation into cementoblasts and periodontal ligament cells. J Periodontal Res. 2020.
Jaberi E, Tresse E, Grønbæk K, Weischenfeldt J, Issazadeh-Navikas S. Identification of unique and shared mitochondrial DNA mutations in neurodegeneration and cancer by single-cell mitochondrial DNA structural variation sequencing (MitoSV-seq). EBioMedicine. 2020;57:102868.
Cahen VC, Li Y, Getz KD, Elgarten CW, DiNofia AM, Wilkes JJ, Winestone LE, Huang Y-SV, Miller TP, M Gramatges M, et al. Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment. Pediatr Blood Cancer. 2020:e28315.
Yamaguchi A, Ishikawa K-I, Inoshita T, Shiba-Fukushima K, Saiki S, Hatano T, Mori A, Oji Y, Okuzumi A, Li Y, et al. Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease. Stem Cell Reports. 2020.
Gu Y, Yang R, Yang Y, Zhao Y, Wakeham A, Li WY, Tseng A, Leca J, Berger T, Saunders M, et al. IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis. Blood. 2020.
Yin N, Xie T, Zhang H, Chen J, Yu J, Liu F. IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR. Oncol Lett. 2020;19(2):1322-1330.

Pages